HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Cosmetics Update: 2013 AE Reports Tallied, 2014 Research Targeted

This article was originally published in The Rose Sheet

Executive Summary

FDA says cosmetic-related adverse events were down in fiscal 2013, but suggests the decline may be due to a falloff in agency outreach and lower consumer awareness. The agency is focused on trace contaminants, with guidance in the works on lipstick lead, and aims to release its final guidance on cosmetic nanomaterials in the coming months, according to Linda Katz, director of FDA’s cosmetics office.

Advertisement

Related Content

FDA Cosmetic Adverse Event Data Beg Question: Mandatory Reporting?
FDA's Cosmetic AE Data Begs Question: What If Reporting Were Mandatory?
Cosmetic Adverse Event Reports Spiked 56% In Fiscal 2014 – FDA
FDA To Issue Guidance On Nano Cosmetics, Lead In Lipstick
Cosmetics Adverse Events Reported To FDA Increase 35% In FY 2012
ICCR Addresses Lead Limit, Endocrine Disruptors At 7th Meeting
In Brief
With AE Reporting Push, FDA Emphasizes Importance Of Cosmetic Safety
Advertisement
UsernamePublicRestriction

Register

RS019381

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel